- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04709484
Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis
Plantar fasciitis, often described as overloading of the plantar fascia, is the most common cause of heel pain in adults. It is characterized by a sharp pain along the medial aspect of the heel, which is worse with the first step taken in the morning or at the beginning of an activity and decreases as the person warms up. The etiology of plantar fasciitis is multifactorial and not well understood. Poor biomechanics and changes in the structure of the foot can lead to repeated micro-trauma at the beginning of the plantar fascia, causing inflammation and degeneration. Plantar fasciitis is more common in sedentary individuals and athletes and those participating in running sports. Other risk factors associated with plantar fasciitis include reduced ankle dorsiflexion, increased body mass index (BMI), and work-related weight loss activities.
Current treatments for plantar fasciitis, such as plantar fascia stretching exercises, strapping, extracorporeal shock wave therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), arch braces, and heel pads are mainly aimed at reducing inflammation. Corticosteroid injections are usually reserved for refractory plantar fasciitis after conservative noninvasive attempts have failed. It has been shown to effectively reduce heel pain in patients with plantar fasciitis. The strong anti-inflammatory effect of corticosteroids can speed up the process of pain relief.
In our study, we aimed to compare the effectiveness of USG and palpation guidance blind steroid injection in patients diagnosed with plantar fasciitis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is planned to enroll 60 (sixty) patients in the study. Patients diagnosed with plantar fasciitis, between the ages of 18-75, who have failed conservative treatment (stretching exercises, non-steroidal anti-inflammatory drugs and heel pads) for at least 3 months, and those with a Visual Anolog Scale value of 5 and above will be included in the study. Any local injection therapy and physical therapy for heel pain in the last 4 months, any surgery history for heel pain, history of tarsal tunnel syndrome, ankle effusion showing intra-articular disease, healed calcaneal fracture, Achilles tendinopathy, foot including pes and any deformity of the ankle, planus or pes cavus deformity; Patients with systemic disorders such as diabetes mellitus, rheumatoid arthritis, hematological disease or gout, pregnancy, history of aspirin or aspirin-like medication, and mental insufficiency will be excluded from the study.
In the study, the patients will be filled in Visual Analogue Scale (VAS) and Foot Function Indez (FFI) questionnaires. Patients will be randomized into 2 groups according to the Random Number Generation. The first group will be the USG-guided steroid injection group, and the second group will be the palpation-guided steroid injection group. In the USG-guided group, steroid injection will be made to the area where the fascia is thickened under the guidance of USG. In the palpation-guided group, the most painful point will be found by palpation on the calcaneus bone and steroid injection will be made to that part. The content of the steroid solution will be 1 ml of 1% Lidocaine + 1 ml (40 mg) methylprednisolone. There will be pre-injection, 1st month and 3rd month controls after injection.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Isparta, Turkey
- Adem ERBİROL
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients diagnosed with plantar fasciitis
- Between the ages of 18-75
- Who have failed conservative treatment (stretching exercises, non-steroidal anti-inflammatory drugs and heel pads) for at least 3 months
- Visual Anolog Scale value of 5 and above will be included in the study.
Exclusion Criteria:
- Having received any local injection therapy and physical therapy for heel pain within the last 4 months,
- Any history of surgery for heel pain, tarsal tunnel syndrome, calcaneal fracture, Achilles tendinopathy, any deformity of the foot and ankle including pes, planus or pes cavus deformity
- with systemic disorders such as diabetes mellitus, rheumatoid arthritis, hematological disease, or gout
- Pregnancy
- A recent history of aspirin or aspirin-like medication
- mental disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: USG-guided steroid injection group
In the USG-guided group, steroid injection will be made to the area where the fascia is thickened under USG guidance.
The content of the steroid solution will be 1 ml of 1% Lidocaine + 1 ml (40 mg) methylprednisolone.
|
In the palpation-guided group, the most painful point will be found by palpation on the calcaneus boIn the USG-guided group, steroid injection will be made to the area where the fascia is thickened under USG guidance.
The content of the steroid solution will be 1 ml of 1% Lidocaine + 1 ml (40 mg) methylprednisolone.ne
and steroid injection will be made to that part.
The content of the steroid solution will be 1 ml of 1% Lidocaine + 1 ml (40 mg) methylprednisolone.
Other Names:
|
EXPERIMENTAL: Palpation-guided steroid injection group
In the palpation-guided group, the most painful point will be found by palpation on the calcaneus bone and steroid injection will be made to that part.
The content of the steroid solution will be 1 ml of 1% Lidocaine + 1 ml (40 mg) methylprednisolone.
|
In the palpation-guided group, the most painful point will be found by palpation on the calcaneus bone and steroid injection will be made to that part.
The content of the steroid solution will be 1 ml of 1% Lidocaine + 1 ml (40 mg) methylprednisolone.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Severity
Time Frame: day 0 (before intervention)
|
visual analog scale (0-10) minimum score: 0 maximum score: 10.
Higher scores reflect more severe pain.
Higher values represent a worse outcome.
|
day 0 (before intervention)
|
Pain Severity
Time Frame: 1 month after intervention
|
visual analog scale (0-10) minimum score: 0 maximum score: 10.
Higher scores reflect more severe pain.
Higher values represent a worse outcome.
|
1 month after intervention
|
Pain Severity
Time Frame: 3 month after intervention
|
visual analog scale (0-10) minimum score: 0 maximum score: 10.
Higher scores reflect more severe pain.
Higher values represent a worse outcome.
|
3 month after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Foot Function Index
Time Frame: day 0 (before intervention)
|
Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain.
The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230.
The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points.
Higher values represent a worse outcome.
|
day 0 (before intervention)
|
Foot Function Index
Time Frame: 1 month after intervention
|
Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain.
The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230.
The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points.
Higher values represent a worse outcome.
|
1 month after intervention
|
Foot Function Index
Time Frame: 3 month after intervention
|
Foot Function Index(FFI) is a self-report questionnaire concerning foot function and pain.
The FFI consists of 23 questions with scores 0-10 in three domains concerning foot pain, function and disability resulting in a total score range from 0 to 230.
The score is validated for patients with plantar fasciitis with a minimal clinical important difference being 7 points.
Higher values represent a worse outcome.
|
3 month after intervention
|
Collaborators and Investigators
Investigators
- Study Director: Adem Erbirol, Egirdir Bone Joint Diseases Treatment And Rehabilitation Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- dr.ademerbirol
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plantar Fasciitis
-
University of VirginiaNot yet recruitingPlantar Fascitis | Plantar Fasciopathy | Plantar Fasciitis, Chronic | Plantar Fasciitis of Both Feet | Plantar Fasciitis of Right Foot | Plantar Fasciitis of Left FootUnited States
-
Cairo UniversityNot yet recruiting
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...RecruitingPlantar FascitisItaly
-
Chinese University of Hong KongRecruiting
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Chinese University of Hong KongRecruitingPlantar FascitisHong Kong
-
Stanford UniversityNot yet recruitingPlantar Fascitis
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
Riphah International UniversityCompletedPlantar FascitisPakistan
-
Universidad Complutense de MadridUnknownPlantar Fasciitis | Ultrasound Therapy | Plantar Fasciitis, ChronicSpain
Clinical Trials on USG-guided steroid injection
-
Istanbul Physical Medicine Rehabilitation Training...CompletedCarpal Tunnel SyndromeTurkey
-
Johns Hopkins UniversityWithdrawn
-
Sultan Qaboos UniversityRecruitingAnalgesia | Varicocele | Hydrocele | Inguinal Surgery | Undescended Testes | Torsion Testis | Ilioinguinal Nerve BlockOman
-
Abant Izzet Baysal UniversityUnknown
-
Chinese University of Hong KongNot yet recruiting
-
Cukurova UniversityErzincan UniversityCompleted
-
Eskisehir Osmangazi UniversityCompleted
-
Sheikh Zayed Medical CollegeCompletedCarpal Tunnel SyndromePakistan
-
Johns Hopkins UniversityMilton S. Hershey Medical Center; United States Naval Medical Center, San Diego and other collaboratorsCompletedSacroiliac Joint PainUnited States
-
College of Medical Sciences Teaching Hospital....UnknownZygomatic Arch Fracture